Fermented Wheat Germ Extract in Women With Ovarian Cancer

Summary

The main purpose of this Pilot Study is to test the safety, tolerability and quality of life in women who take Fermented Wheat Germ Extract (FWGE), to determine if an active form of FWGE can be detected in the blood, and determine whether short-term therapy with FWGE has any effect on the tumor marker, cancer antigen 125 (CA-125).

Timeline

Start

2016-03-01

Primary completion

2017-12-15

Completion

2018-01-08

Outcome

Outcome not reported

Stopped: “Drug manufacturing issues”

Drugs

Indications